Toxicity of MRI and CT contrast agents

@article{Hasebroock2009ToxicityOM,
  title={Toxicity of MRI and CT contrast agents},
  author={Kendra M. Hasebroock and Natalie J. Serkova},
  journal={Expert Opinion on Drug Metabolism \& Toxicology},
  year={2009},
  volume={5},
  pages={403 - 416}
}
Anatomical and physiological imaging using CT and MRI are playing a critical role in patients’ diagnosis, disease characterization and treatment planning. CT- and MRI-based protocols increasingly require an injection of iodinated CT and gadolinium (Gd)-based MRI contrast media. Although routinely used in clinical practice, iodinated and to a less extent Gd-based contrast media possess side effects: life-threatening contrast-induced nephropathy (CIN) is associated with CT and nephrogenic… Expand
X-ray-computed tomography contrast agents.
TLDR
The strong relationship between absorption and atomic number is of significant importance in clinical applications and the Z4 factor allows for contrast levels of several orders of magnitude between different tissues and types of contrast agents. Expand
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
TLDR
An association with GBCAs in the development of NSF is suggested in the setting of renal insufficiency, but other factors seem to play a role. Expand
Findings in whole body MRI and conventional imaging in patients with fever of unknown origin-a retrospective study
TLDR
Wb-MRI appears to be of value in the evaluation of FUO patients, allowing for optimized treatment by increasing diagnostic certainty and due to its lack of nephrotoxicity and ionizing radiation it may be preferred over standard imaging techniques and PET-CT in the future. Expand
Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives.
TLDR
The fundamental principles of MRI contrast agents are discussed, and the current status ofMRI contrast agents is reviewed with a focus on the advantages and limitations of current T1 contrast agents and the potential of IONPs to serve as safe and improved alternative to gadolinium-based chelates. Expand
Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
TLDR
Among the known risk factors, such as preexisting renal disease, high serum creatinine level, and low hemoglobin level, a statistically significant association was identified between CM-induced nephropathy and concurrent receipt of four nephrotoxic medications. Expand
The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
TLDR
The incidence of CIN in patients with diabetes and chronic kidney disease receiving IV contrast medium was not significantly different after CT using iopamidol 370 or iodixanol 320. Expand
Albumin-mediated platinum nanocrystals for in vivo enhanced computed tomography imaging.
TLDR
It was demonstrated that the nanocrystals could serve as potential new and potent CT contrast agents, especially vital for in vivo imaging with prominent enhancement and metabolizable behaviours due to the combination of the higher X-ray attenuation property and prolonged imaging time, perhaps caused by the BSA modification. Expand
Adaptive radiotherapy based on contrast enhanced cone beam CT imaging
Abstract Cone beam CT (CBCT) imaging has become an integral part of radiation therapy, with images typically used for offline or online patient setup corrections based on bony anatomyExpand
Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip Cartilage.
TLDR
An optimized and efficient large-scale synthesis of a cationic iodinated contrast agent (CA4+) is described for imaging articular cartilage and its attenuation correlates with the glycosaminoglycan content, equilibrium modulus, and coefficient of friction, which are key indicators of cartilage functional performance and osteoarthritis stage. Expand
Assessment of biliary anatomy in potential living liver donors: Added value of gadoxetic acid-enhanced T1 MR Cholangiography (MRC) including utilization of controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) technique in co.
TLDR
Gadoxetic-acid-enhanced T1-weighted magnetic resonance Cholangiography and conventional T2W-MRC techniques are complementary for depiction of biliary variants in potential liver donors and the combination of the two improves the results. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 104 REFERENCES
Imaging patients with chronic kidney disease: CIN or NSF?
TLDR
In order to optimise patient outcomes, imaging of patients with CKD requires an understanding of the risk factors for both CIN and NSF. Expand
Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern
TLDR
Caution should be exercised when utilizing gadolinium as a contrast agent in patients with advanced CKD or ESRD, especially those with diabetic nephropathy. Expand
Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?
TLDR
A patient with reduced renal function faces the unpleasant choice of risking contrast medium-induced nephropathy (CIN) after administration of iodine-based CM or NSF after exposure to gadolinium-basedCM, and new knowledge has complicated work in the imaging department. Expand
New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice.
TLDR
Contrast enhanced ultrasound enables the characterisation of focal liver lesions, regardless of the presence or absence of underlying chronic liver disease, and is also useful in staging and follow-up of cancer patients and in monitoring local ablative treatment. Expand
Extracellular gadolinium-based contrast media: an overview.
TLDR
This review describes the current status of gadolinium-CA, their mechanism of action, chemical structure, pharmacokinetics, dosage, elimination, nephrotoxicity and adverse events. Expand
Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
TLDR
Gadolinium-based contrast media are safe and well tolerated by the vast majority of patients and the adverse reaction rate and the incidence of severe anaphylactoid reaction concur with those reported in the literature. Expand
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
TLDR
The situation regarding gadolinium based contrast agent and the severe delayed reaction to some of these agents is reviewed and the fear of nephrogenic systemic fibrosis should not lead to a denial of a well indicated enhanced magnetic resonance imaging examination. Expand
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
TLDR
An association with GBCAs in the development of NSF is suggested in the setting of renal insufficiency, but other factors seem to play a role. Expand
Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT – A pooled analysis of two randomized trials
TLDR
Following the IV administration of nonionic contrast agents in patients with moderate-to-severe renal insufficiency, the risk of significant CIN seems to be low and differences in osmolality between these LOCM and iodixanol do not play a role in the genesis of CIN. Expand
Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.
TLDR
It is shown that gadodiamide plays a causative role in nephrogenic systemic fibrosis, and seven patients became severely disabled, and one died 21 mo after exposure. Expand
...
1
2
3
4
5
...